Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
2.500
-0.050 (-1.96%)
Mar 28, 2025, 4:25 PM CET
133.64%
Market Cap 786.02M
Revenue (ttm) n/a
Net Income (ttm) -42.21M
Shares Out 314.41M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,582,595
Average Volume 2,151,122
Open 2.490
Previous Close 2.550
Day's Range 2.415 - 2.590
52-Week Range 0.956 - 4.995
Beta n/a
RSI 55.83
Earnings Date Mar 28, 2025

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was founded in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 2
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.